melanoma
Attenuation of MAP3K9 function in melanoma cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in melanoma.
Attenuation of <span class="gene" id="22197930-7-15-21">MAP3K9</span> function in <span class="disease" id="22197930-7-34-42">melanoma</span> cells using siRNA led to increased cell viability after temozolomide treatment, suggesting that decreased MAP3K pathway activity can lead to chemoresistance in <span class="disease" id="22197930-7-203-211">melanoma</span>.